162 related articles for article (PubMed ID: 23056327)
1. Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism.
Xiao Y; Li Y; Han J; Pan Y; Tie L; Li X
PLoS One; 2012; 7(10):e46510. PubMed ID: 23056327
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin inhibits the thrombin-induced loss of barrier integrity in bovine corneal endothelium.
Shivanna M; Jalimarada SS; Srinivas SP
J Ocul Pharmacol Ther; 2010 Feb; 26(1):1-10. PubMed ID: 20148651
[TBL] [Abstract][Full Text] [Related]
4. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.
Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2424-32. PubMed ID: 15980231
[TBL] [Abstract][Full Text] [Related]
5. Transgelin mediates transforming growth factor-β1-induced proliferation of human periodontal ligament cells.
Mitarai H; Wada N; Hasegawa D; Yoshida S; Sonoda M; Tomokiyo A; Hamano S; Serita S; Mizumachi H; Maeda H
J Periodontal Res; 2017 Dec; 52(6):984-993. PubMed ID: 28590058
[TBL] [Abstract][Full Text] [Related]
6. Myosin, transgelin, and myosin light chain kinase: expression and function in asthma.
Léguillette R; Laviolette M; Bergeron C; Zitouni N; Kogut P; Solway J; Kachmar L; Hamid Q; Lauzon AM
Am J Respir Crit Care Med; 2009 Feb; 179(3):194-204. PubMed ID: 19011151
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin induces the expression of bradykinin type 2 receptors in cultured human coronary artery endothelial cells.
Liesmaa I; Kokkonen JO; Kovanen PT; Lindstedt KA
J Mol Cell Cardiol; 2007 Nov; 43(5):593-600. PubMed ID: 17900611
[TBL] [Abstract][Full Text] [Related]
9. Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells.
Srinivas SP; Satpathy M; Guo Y; Anandan V
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4011-8. PubMed ID: 16936117
[TBL] [Abstract][Full Text] [Related]
10. JunB mediates basal- and TGFβ1-induced smooth muscle cell contractility.
Ramachandran A; Gangopadhyay SS; Krishnan R; Ranpura SA; Rajendran K; Ram-Mohan S; Mulone M; Gong EM; Adam RM
PLoS One; 2013; 8(1):e53430. PubMed ID: 23308222
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide donor NaHS induces death of alveolar epithelial L2 cells that is associated with cellular shrinkage, transgelin expression and myosin phosphorylation.
Fujii Y; Funakoshi T; Unuma K; Noritake K; Aki T; Uemura K
J Toxicol Sci; 2016; 41(5):645-54. PubMed ID: 27665774
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling.
Essler M; Staddon JM; Weber PC; Aepfelbacher M
J Immunol; 2000 Jun; 164(12):6543-9. PubMed ID: 10843713
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequencing of cDNAs encoding the actin cross-linking protein transgelin defines a new family of actin-associated proteins.
Prinjha RK; Shapland CE; Hsuan JJ; Totty NF; Mason IJ; Lawson D
Cell Motil Cytoskeleton; 1994; 28(3):243-55. PubMed ID: 7954852
[TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic mechanisms of simvastatin in retinal endothelial cells.
Hata Y; Miura M; Asato R; Kita T; Oba K; Kawahara S; Arita R; Kohno R; Nakao S; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):667-73. PubMed ID: 20155363
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability.
Wu L; Ramirez SH; Andrews AM; Leung W; Itoh K; Wu J; Arai K; Lo EH; Lok J
J Neurochem; 2016 Jan; 136(2):250-7. PubMed ID: 26438054
[TBL] [Abstract][Full Text] [Related]
18. Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines.
Dvorakova M; Lapcik P; Bouchalova P; Bouchal P
Proteomics; 2020 Apr; 20(7):e1900383. PubMed ID: 32061197
[TBL] [Abstract][Full Text] [Related]
19. Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells.
Chung HK; Lee IK; Kang H; Suh JM; Kim H; Park KC; Kim DW; Kim YK; Ro HK; Shong M
Exp Mol Med; 2002 Dec; 34(6):451-61. PubMed ID: 12526087
[TBL] [Abstract][Full Text] [Related]
20. M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells.
Surks HK; Riddick N; Ohtani K
J Biol Chem; 2005 Dec; 280(52):42543-51. PubMed ID: 16257966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
